Skip navigation

BioWednesday Cambridge: The Role of AI and Big Data in Drug Discovery

17:30 - 20:30

Location:
Barclays Eagle Labs Incubator, 28 Chesterton Rd, Cambridge CB4 3AZ
Date:
18 April 2018
 

This event is now at capacity. If you would like to be added to the wait list please or have any questions please email nadia@onenucleus.com.


Sponsored by:


 

Artificial Intelligence is becoming increasingly more important in the Healthcare Sector and technology companies are now working alongside pharmaceutical companies to optimise the drug discovery process. These new partnerships aim to reduce the time and cost of getting medicines to market.

In this BioWednesday, sponsored by Appleyard Lees, we will hear from different companies involved in the space and learn about the exciting opportunities in the Healthcare Sector.

For those of you interested in learning more, there will also be a session on this topic at ON Helix 2018.



Programme:
17.30 - Registration, Tea and Coffee


18.00 - Welcome from Host and One Nucleus

18.10 – Company Introductions
GTN

AstraZeneca

GSK

AI VIVO

18.30 - Panel Discussion: The Role of AI and Big Data in Drug Discovery

Chair:

Julia Gwilt
, Appleyard Lees

Panellists:
Noor Shaker, GTN

Stefan Platz, AstraZeneca

Lindsay Edwards, GSK

Peyman Gifani, AI VIVO


19.20 - Networking over Drinks and Canapés

20.30 – Close


Prices:
Members: free 
Non-members: £50 (plus vat) 
Academics: please contact nadia@onenucleus.com




Title: BioWednesday Cambridge: The Role of AI and Big Data in Drug Discovery
Start: 2018-04-18 17:30:00Z
End: 2018-04-18 20:30:00Z